Despite some recent findings demonstrating that TCF consensus sites for β-catenin were functional in the ABCB1 promoter in other types of cancer, in CML, this regulation has not yet been investigated. The gene discussed is HNF4A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.